Quick Links
A treatment performed by retina specialists to manage serious eye conditions including macular degeneration, diabetic macular edema, and retinal vein occlusion.
How It Works
Medication is injected directly into the vitreous of the eye to target the underlying cause of these conditions, typically abnormal blood vessel growth or fluid leakage that threatens vision.
Available Medications
- Eylea and Eylea HD – Anti-VEGF therapy for macular degeneration and diabetic edema
- Avastin – A widely used off-label anti-VEGF treatment
- Vabysmo – A dual-action treatment targeting two pathways that drive retinal disease
- Syfovre – Used for the treatment of geographic atrophy secondary to dry AMD
- Lucentis – An anti-VEGF therapy for multiple retinal conditions
Key Benefits
- Targets the root cause of vision-threatening retinal conditions
- Helps preserve and in some cases improve vision
- Multiple medication options tailored to each patient’s condition